DPP4 and prostate carcinoma: It has been recently reported that the expression level of CD26 in prostate cancer tissues is higher than that of normal prostatic tissues and increased with prostate cancer stage advancement, and CD26 expression is correlated with prostate specific antigen, suggesting that CD26 may be a good marker for prostate cancer diagnosis[28].